Astellas Pharma Inc. (4503.T)
JPY 1521.5
(0.8%)
JPY 1521.5
(0.8%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 9.50 JPY | -82.49% |
| 2022 | 54.24 JPY | -19.14% |
| 2021 | 67.08 JPY | 3.31% |
| 2020 | 64.93 JPY | -37.66% |
| 2019 | 104.15 JPY | -9.47% |
| 2018 | 115.05 JPY | 41.84% |
| 2017 | 81.11 JPY | -21.78% |
| 2016 | 103.69 JPY | 15.53% |
| 2015 | 89.75 JPY | 45.93% |
| 2014 | 61.50 JPY | 52.04% |
| 2013 | 40.45 JPY | 25.54% |
| 2012 | 32.22 JPY | 280.4% |
| 2011 | 8.47 JPY | -71.09% |
| 2010 | 29.30 JPY | -44.05% |
| 2009 | 52.37 JPY | -26.47% |
| 2008 | 71.22 JPY | 1.77% |
| 2007 | 69.98 JPY | 50.3% |
| 2006 | 46.56 JPY | 28.9% |
| 2005 | 36.12 JPY | 93.88% |
| 2004 | 18.63 JPY | -21.36% |
| 2003 | 23.69 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.81 JPY | -5.05% |
| 2024 Q1 | 21.00 JPY | 214.19% |
| 2023 Q1 | 18.46 JPY | 172.42% |
| 2023 Q2 | -0.81 JPY | -104.39% |
| 2023 FY | - JPY | -82.49% |
| 2023 Q3 | 8.09 JPY | 1098.77% |
| 2023 Q4 | -18.39 JPY | -327.32% |
| 2022 Q4 | -25.49 JPY | -195.97% |
| 2022 Q2 | 39.30 JPY | 188.97% |
| 2022 FY | - JPY | -19.14% |
| 2022 Q1 | 13.60 JPY | 397.59% |
| 2022 Q3 | 26.56 JPY | -32.42% |
| 2021 Q1 | 16.56 JPY | 349.4% |
| 2021 Q2 | 22.09 JPY | 33.39% |
| 2021 Q4 | -4.57 JPY | -113.91% |
| 2021 FY | - JPY | 3.31% |
| 2021 Q3 | 32.86 JPY | 48.76% |
| 2020 Q3 | 32.34 JPY | 167.94% |
| 2020 FY | - JPY | -37.66% |
| 2020 Q1 | 27.14 JPY | 845.64% |
| 2020 Q2 | 12.07 JPY | -55.53% |
| 2020 Q4 | -6.64 JPY | -120.53% |
| 2019 Q3 | 32.80 JPY | -11.66% |
| 2019 FY | - JPY | -9.47% |
| 2019 Q1 | 31.03 JPY | 93.94% |
| 2019 Q2 | 37.13 JPY | 19.66% |
| 2019 Q4 | 2.87 JPY | -91.25% |
| 2018 Q2 | 25.50 JPY | -7.88% |
| 2018 Q3 | 45.64 JPY | 78.98% |
| 2018 Q4 | 16.00 JPY | -64.94% |
| 2018 FY | - JPY | 41.84% |
| 2018 Q1 | 27.68 JPY | 153.02% |
| 2017 Q2 | 19.39 JPY | -5.74% |
| 2017 FY | - JPY | -21.78% |
| 2017 Q4 | 10.94 JPY | -63.53% |
| 2017 Q3 | 30.00 JPY | 54.72% |
| 2017 Q1 | 20.57 JPY | 8.66% |
| 2016 Q2 | 22.80 JPY | -27.27% |
| 2016 Q4 | 18.93 JPY | -37.4% |
| 2016 Q3 | 30.24 JPY | 32.63% |
| 2016 Q1 | 31.35 JPY | 131.19% |
| 2016 FY | - JPY | 15.53% |
| 2015 Q2 | 26.96 JPY | 32.29% |
| 2015 Q1 | 20.38 JPY | 113.18% |
| 2015 FY | - JPY | 45.93% |
| 2015 Q4 | 13.56 JPY | -52.7% |
| 2015 Q3 | 28.67 JPY | 6.34% |
| 2014 Q3 | 20.27 JPY | 31.11% |
| 2014 Q2 | 15.46 JPY | -4.27% |
| 2014 FY | - JPY | 52.04% |
| 2014 Q1 | 16.15 JPY | 280.9% |
| 2014 Q4 | 9.56 JPY | -52.84% |
| 2013 FY | - JPY | 25.54% |
| 2013 Q4 | 4.24 JPY | -71.7% |
| 2013 Q3 | 14.98 JPY | 31.4% |
| 2013 Q2 | 11.40 JPY | 29.69% |
| 2013 Q1 | 8.79 JPY | 1212.66% |
| 2012 Q4 | -0.79 JPY | -106.55% |
| 2012 FY | - JPY | 280.4% |
| 2012 Q1 | 15.37 JPY | 274.26% |
| 2012 Q2 | 9.49 JPY | -38.26% |
| 2012 Q3 | 12.07 JPY | 27.19% |
| 2011 Q1 | 10.89 JPY | 318.67% |
| 2011 Q2 | 11.34 JPY | 4.13% |
| 2011 Q3 | 20.47 JPY | 80.51% |
| 2011 Q4 | -8.82 JPY | -143.09% |
| 2011 FY | - JPY | -71.09% |
| 2010 Q4 | -4.98 JPY | -132.05% |
| 2010 FY | - JPY | -44.05% |
| 2010 Q1 | 17.09 JPY | 594.72% |
| 2010 Q2 | 1.95 JPY | -88.59% |
| 2010 Q3 | 15.54 JPY | 696.92% |
| 2009 Q1 | 18.73 JPY | 136.79% |
| 2009 Q2 | 16.80 JPY | -10.3% |
| 2009 Q3 | 12.93 JPY | -23.04% |
| 2009 Q4 | 2.46 JPY | -80.97% |
| 2009 FY | - JPY | -26.47% |
| 2008 FY | - JPY | 1.77% |
| 2008 Q4 | 7.91 JPY | -66.6% |
| 2008 Q3 | 23.68 JPY | 34.32% |
| 2008 Q2 | 17.63 JPY | 0.0% |
| 2007 FY | - JPY | 50.3% |
| 2006 FY | - JPY | 28.9% |
| 2005 FY | - JPY | 93.88% |
| 2004 FY | - JPY | -21.36% |
| 2003 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 151.03 JPY | 93.71% |
| Chugai Pharmaceutical Co., Ltd. | 197.83 JPY | 95.198% |
| Ono Pharmaceutical Co., Ltd. | 266.61 JPY | 96.437% |
| Santen Pharmaceutical Co., Ltd. | 72.62 JPY | 86.918% |
| JCR Pharmaceuticals Co., Ltd. | 44.13 JPY | 78.473% |
| Daiichi Sankyo Company, Limited | 104.69 JPY | 90.926% |
| Otsuka Holdings Co., Ltd. | 224.11 JPY | 95.761% |
| Perseus Proteomics Inc. | -93.69 JPY | 110.14% |